Consun Pharmaceutical Group Limited (HKG:1681)
9.57
+0.17 (1.81%)
May 15, 2025, 4:08 PM HKT
HKG:1681 Revenue
In the year 2024, Consun Pharmaceutical Group had annual revenue of 2.97B CNY with 14.56% growth. Consun Pharmaceutical Group had revenue of 1.70B in the half year ending December 31, 2024, with 26.19% growth.
Revenue
2.97B CNY
Revenue Growth
+14.56%
P/S Ratio
2.52
Revenue / Employee
937.81K CNY
Employees
3,164
Market Cap
7.97B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.97B | 377.12M | 14.56% |
Dec 31, 2023 | 2.59B | 250.47M | 10.71% |
Dec 31, 2022 | 2.34B | 294.99M | 14.43% |
Dec 31, 2021 | 2.04B | 291.83M | 16.65% |
Dec 31, 2020 | 1.75B | 24.57M | 1.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Alibaba Health Information Technology | 31.39B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Sino Biopharmaceutical | 30.72B |